Form 4: Opus Genetics Director Receives RSU Grant

Opus Genetics Director Cam Gallagher was granted 67,000 restricted stock units, vesting in December 2026.

Summary

• Director Cam Gallagher of Opus Genetics, Inc. acquired 67,000 shares of Common Stock on January 6, 2026.
• These shares represent a grant of restricted stock units (RSUs) with a vesting date of December 29, 2026, contingent on continued service.
• Following this transaction, Gallagher directly beneficially owns 1,991,430 shares of Common Stock.
• Additionally, 83,000 shares are indirectly held by Gallagher as custodian for a minor child under the Uniform Transfer to Minors Act (UTMA/UGMA), with beneficial ownership disclaimed except for any pecuniary interest.

Sentiment

Score: 6

Explanation: The grant of restricted stock units to a director is a neutral to slightly positive event, indicating continued alignment of management interests with the company's long-term performance. It's a routine compensation event.

Positives

• The grant of 67,000 restricted stock units to a director aligns management incentives with long-term company performance.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of director's interests with long-term company performance through equity compensation.

Key Dates

Recommendation

This Form 4 reports a routine grant of restricted stock units to a director, which is a standard compensation practice. It does not provide new information that would fundamentally alter the investment thesis for Opus Genetics, Inc. Therefore, a 'hold' recommendation is appropriate, pending further financial or operational updates.

Keywords

Opus Genetics, IRD, Form 4, Insider Transaction, Restricted Stock Units, RSU Grant, Director Compensation, Equity Compensation, Cam Gallagher